RENERVE LIMITED

9.09%

12.0¢

Market Cap $13.13M

Healthcare Medical Devices

ReNerve Limited is an Australia-based biotechnology company engaged in advanced nerve... ReNerve Limited is an Australia-based biotechnology company engaged in advanced nerve repair and regeneration solutions. The Company is focused on commercializing medical devices and tissue engineering products that address significant unmet needs in peripheral nerve damage patients. It is also developing tissue-based products for peripheral nerve repair and replacement and other related soft tissue surgical procedures. It is focused on developing products that accelerate tissue regeneration while preventing scarring and negative inflammatory responses. Its products include NervAlign Nerve Cuff, NervAlign Nerve Graft and NervAlign Bionic Nerve. NervAlign Nerve Cuff is a soft, tissue compatible protective wrap used to protect repaired injured nerves. It consists of a pliable scaffolding material that can be wrapped around the nerve, protecting surgical repairs and conforming to the nerve’s final shape, allowing regeneration to occur. More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Latest Threads

Tag

Subject

RNV

Ann: Investor presentation - the Berkeley Biologics Partnership

03/06/25

442

03/06/25

Last post jad666

442

RNV

Ann: Expands Product Portfolio with Berkley partnership / Webinar

02/06/25

448

02/06/25

Last post

ASX News

448

RNV

ReNerve snaffles approval in Bahrain, looks to expand throughout the ME

28/05/25

176

28/05/25

Last post ASX Insights

176

RNV

Ann: ReNerve receives market approval in Bahrain

28/05/25

460

28/05/25

Last post seaforth1

460

RNV

Ann: Change of Director's Interest Notice - S Cooper

09/05/25

911

09/05/25

Last post RandAlThor1

911

RNV

Ann: Quarterly Investor Presentation

07/05/25

348

07/05/25

Last post

ASX News

348

RNV

Ann: Notification regarding unquoted securities - RNV

30/04/25

503

30/04/25

Last post RandAlThor1

503

RNV

Ann: Quarterly Investor Webinar

29/04/25

235

29/04/25

Last post

ASX News

235

See All Discussions

Timeline

Investor presentation - the Berkeley Biologics Partnership
03 Jun 10:41	Share

Expands Product Portfolio with Berkley partnership / Webinar
02 Jun 09:37	Share

ReNerve receives market approval in Bahrain
28 May 09:46	Share

Change of Director's Interest Notice - S Cooper
09 May 08:48	Share

Quarterly Investor Presentation
07 May 10:25	Share

Notification regarding unquoted securities - RNV
30 Apr 10:07	Share

Quarterly Investor Webinar
29 Apr 10:16	Share

ReNerve - Q3 FY25 Activities Report & Appendix 4C
29 Apr 10:13	Share

Change in substantial holding
17 Apr 14:05	Share

Expands Global Footprint with Strategic Partnership in India
10 Apr 09:29	Share

Response to ASX Aware Letter
31 Mar 16:51	Share

Clinical Outcome Demonstrates Material Benefits for Patients
28 Mar 09:39	Share

Notification of cessation of securities - RNV
26 Mar 08:30	Share

Change of Director's Interest Notice - J Chick
20 Mar 08:21	Share

Cleansing Notice
14 Mar 08:25	Share

Application for quotation of securities - RNV
14 Mar 08:22	Share

Proposed issue of securities - RNV
13 Mar 08:21	Share

Marketing Approval in Thailand & Initial Sales in Hong Kong
11 Mar 09:52	Share

ReNerve Receives Additional $139K R&D Refund
07 Mar 09:53	Share

1HFY25 Results Announcement
28 Feb 09:45	Share

1HFY25 Appendix 4D and Half Year Report
28 Feb 09:44	Share

ReNerve enters distribution partnership in Mexico
27 Feb 09:46	Share

Change of Director's Interest Notice - M Panaccio
14 Feb 08:20	Share

Change of Director's Interest Notice - J Chick
10 Feb 09:32	Share

Quarterly Investor Presentation
06 Feb 10:29	Share

Investor Webinar Update
31 Jan 09:33	Share

ReNerve - Q2 FY25 Activities Report & Appendix 4C
29 Jan 09:57	Share

Becoming a substantial holder
09 Jan 15:42	Share

Change in substantial holding
18 Dec 12:01	Share

Change of Director's Interest Notice - S Cooper
18 Dec 12:01	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 12.0¢		Change 0.010(9.09%)		Mkt cap ! $13.13M

Open	High	Low	Value	Volume
12.0¢	12.0¢	12.0¢	$3.285K	27.37K

Buyers (Bids)

No.	Vol.	Price($)
1	90909	11.0¢

Sellers (Offers)

Price($)	Vol.	No.
12.0¢	122717	3

View Market Depth

No.	Vol.	Price($)
1	90909	0.110
2	47047	0.105
4	162500	0.100
1	10526	0.095
1	6000	0.090

Price($)	Vol.	No.
0.120	122717	3
0.135	25000	1
0.140	25000	1
0.145	25000	1
0.150	50000	2

Last trade - 14.26pm 13/06/2025 (20 minute delay)

RNV (ASX) Chart

RENERVE LIMITED

Corporate Spotlight
Not Yet Available

Latest Threads

Timeline

Featured News

Latest Articles

ReNerve snaffles approval in Bahrain, looks to expand throughout the ME

ReNerve Ltd has received marketing approval from Bahrain which will see its nerve repair devices commercialised throughout the country

ReNerve jumps +45% as 13 patients report pain decrease follow nerve repair surgery

Renerve has popped nearly +50% after reporting 13 patients using ReNerve's 'Nerve Cuff' led to a reduction of pain following nerve surgery.

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News

RENERVE LIMITED

Corporate SpotlightNot Yet Available

Latest Threads

Timeline

Featured News

Latest Articles

ReNerve snaffles approval in Bahrain, looks to expand throughout the ME

ReNerve Ltd has received marketing approval from Bahrain which will see its nerve repair devices commercialised throughout the country

ReNerve jumps +45% as 13 patients report pain decrease follow nerve repair surgery

Renerve has popped nearly +50% after reporting 13 patients using ReNerve's 'Nerve Cuff' led to a reduction of pain following nerve surgery.

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News

Corporate Spotlight
Not Yet Available